We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
-3.43%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$32.1B
AUM Growth
-$2.41B
Cap. Flow
-$988M
Cap. Flow %
-3.08%
Top 10 Hldgs %
22.71%
Holding
1,901
New
52
Increased
542
Reduced
1,211
Closed
85

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$52.1M
2
PEP icon
PepsiCo
PEP
+$38.7M
3
TGT icon
Target
TGT
+$34.6M
4
COST icon
Costco
COST
+$34.1M
5
TTD icon
Trade Desk
TTD
+$33.4M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$426M
2
NVDA icon
NVIDIA
NVDA
+$377M
3
AMZN icon
Amazon
AMZN
+$236M
4
AAPL icon
Apple
AAPL
+$170M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$145M

Sector Composition

Rank Sector Weight
1 Technology 26.25%
2 Industrials 11.99%
3 Consumer Staples 11.34%
4 Consumer Discretionary 10.09%
5 Healthcare 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOSS icon
1801
Gossamer Bio
GOSS
$71.2M
$12.3K ﹤0.01%
+14,730
New +$17K
NGM
1802
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$11.8K ﹤0.01%
11,069
+72
+0.7% +$149
CTXR icon
1803
Citius Pharmaceuticals
CTXR
$13.1M
$10.9K ﹤0.01%
639
ADAP
1804
DELISTED
Adaptimmune Therapeutics
ADAP
$10.5K ﹤0.01%
+13,466
New +$11.3K
SKIL icon
1805
Skillsoft
SKIL
$56.1M
$10.1K ﹤0.01%
568
+47
+9% +$1.19K
WKHS icon
1806
Workhorse Group
WKHS
$30.6M
$9.44K ﹤0.01%
8
+1
+14% +$2.57K
LLAP
1807
DELISTED
Terran Orbital Corporation
LLAP
$9.21K ﹤0.01%
11,070
-14
-0.1% -$19
CRGE
1808
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
$8.7K ﹤0.01%
17,500
-20
-0.1% -$15
CANO
1809
DELISTED
Cano Health, Inc.
CANO
$8.31K ﹤0.01%
328
+17
+5% +$1.4K
AEVA
1810
Aeva Technologies
AEVA
$1.09B
$7.9K ﹤0.01%
2,065
-2
-0.1% -$11
BHIL
1811
DELISTED
Benson Hill, Inc.
BHIL
$7.46K ﹤0.01%
643
-1
-0.2% -$31
NKTR icon
1812
Nektar Therapeutics
NKTR
$2.2B
$7.4K ﹤0.01%
829
+13
+2% +$125
INO icon
1813
Inovio Pharmaceuticals
INO
$88M
$6.82K ﹤0.01%
1,460
+43
+3% +$238
OTLK icon
1814
Outlook Therapeutics
OTLK
$205M
$4.45K ﹤0.01%
1,008
-1
-0.1% -$22
HLTH
1815
DELISTED
Cue Health Inc. Common Stock
HLTH
$4.44K ﹤0.01%
+10,036
New +$4.58K
TCRT icon
1816
Alaunos Therapeutics
TCRT
$4.93M
$2.07K ﹤0.01%
105
+1
+1% +$43
AAP icon
1817
Advance Auto Parts
AAP
$3.14B
-8,948
Closed -$629K
ALGT icon
1818
Allegiant Air
ALGT
$2.74B
-2,467
Closed -$312K
AMRC icon
1819
Ameresco
AMRC
$1.19B
-4,184
Closed -$203K
ARVN icon
1820
Arvinas
ARVN
$517M
-9,842
Closed -$244K
CAR icon
1821
Avis
CAR
$5.62B
-1,393
Closed -$319K
CLDX icon
1822
Celldex Therapeutics
CLDX
$2.79B
-6,043
Closed -$205K
CNXC icon
1823
Concentrix
CNXC
$1.5B
-2,495
Closed -$201K
CTS icon
1824
CTS Corp
CTS
$1.68B
-4,906
Closed -$209K
CUZ icon
1825
Cousins Properties
CUZ
$5.19B
-8,861
Closed -$202K

Similar funds

ProShare Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, ProShare Advisors held 1,901 positions worth $32.1B, down 7% from $34.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

ProShare Advisors withdrew a net $988M in Q3 2023, closing 85 positions and reducing 1,211 holdings. Its most notable exit was DoorDash, an estimated $5.57M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Industrials and Consumer Staples.

Against the trend, ProShare Advisors opened a new position in Trade Desk worth $32.3M.

  • ProShare Advisors's largest Q3 2023 buy was Trade Desk: 413,129 shares worth $32.3M.
  • ProShare Advisors added most to Broadcom in Q3 2023, an estimated $52.1M increase.
  • ProShare Advisors's biggest Q3 2023 reduction was Microsoft, cutting an estimated $426M.
  • ProShare Advisors fully exited DoorDash in Q3 2023, selling an estimated $5.57M.
  • ProShare Advisors's ten largest holdings make up 23% of its $32.1B portfolio in Q3 2023.
  • ProShare Advisors opened 52 new positions and closed 85 in Q3 2023.
  • ProShare Advisors's portfolio value fell 7% quarter-over-quarter to $32.1B.

Based on ProShare Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.